Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,006,229
+$29,692 QoQ
Shares Held
3,962
-0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#1,280
of 2,126 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VALLEY NATIONAL ADVISERS INC holds $26,573,081 across 16 Drug Manufacturers - General names. JNJ ranks #8 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,036 | $6,040,329 | |
| 2 | MRK |
Merck & Co., Inc.
|
44,957 | $5,776,974 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
30,848 | $3,897,336 | |
| 4 | AMGN |
Amgen Inc
|
10,266 | $3,717,523 | |
| 5 | AZN |
Astrazeneca PLC
|
13,217 | $2,506,207 | |
| 6 | ABBV |
AbbVie Inc.
|
5,759 | $1,449,194 | |
| 7 | NVS |
Novartis AG
|
7,794 | $1,221,475 | |
| 8 | JNJ |
Johnson & Johnson
This page
|
3,962 | $1,006,229 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,006,229 | 3,962 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $976,537 | 3,995 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $842,493 | 4,071 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $696,437 | 3,756 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $512,476 | 3,355 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $573,143 | 3,456 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $508,917 | 3,519 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $592,491 | 3,656 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $966,702 | 6,614 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $1,234,831 | 7,806 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $1,241,224 | 7,919 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $1,246,467 | 8,003 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,310,587 | 7,918 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,223,415 | 7,893 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $1,421,325 | 8,046 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $1,344,289 | 8,229 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,458,422 | 8,216 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,455,767 | 8,214 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,428,605 | 8,351 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,364,513 | 8,449 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,391,558 | 8,447 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,419,655 | 8,638 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,381,481 | 8,778 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,307,910 | 8,785 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,202,245 | 8,549 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,140,437 | 8,697 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||